Teitur Trophics is a Danish biotech company, with a mission to develop innovative treatments for neurodegenerative diseases. Founded in 2020, the company's name, "Teitur," is derived from Old Norse for happiness, reflecting their commitment to improving the lives of those affected by neurodegenerative conditions. Specializing in the biotechnology sector, Teitur Trophics recently secured a significant €28.00M Series A investment on 14 March 2023. The investors in this round included Industrifonden, Sunstone Capital, Innovestor, Sound Bioventures, and p53.
No recent news or press coverage available for Teitur Trophics.